INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 346 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $576 | -22.5% | 18,223 | 0.0% | 0.00% | -20.0% |
| Q2 2023 | $743 | +32.9% | 18,223 | +21.4% | 0.01% | +25.0% |
| Q1 2023 | $559 | +2.0% | 15,012 | -4.4% | 0.00% | 0.0% |
| Q4 2022 | $548 | -99.9% | 15,700 | -5.5% | 0.00% | -42.9% |
| Q3 2022 | $929,000 | +46.1% | 16,609 | +35.2% | 0.01% | +40.0% |
| Q2 2022 | $636,000 | -28.8% | 12,282 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $893,000 | -40.0% | 12,282 | 0.0% | 0.01% | -37.5% |
| Q4 2021 | $1,489,000 | -10.2% | 12,282 | -0.6% | 0.01% | -11.1% |
| Q3 2021 | $1,658,000 | -23.7% | 12,357 | -69.1% | 0.01% | -40.0% |
| Q4 2020 | $2,172,000 | +176.0% | 39,935 | +0.9% | 0.02% | +150.0% |
| Q3 2020 | $787,000 | +4042.1% | 39,571 | +4331.2% | 0.01% | – |
| Q2 2020 | $19,000 | – | 893 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 572,950 | $19,990,226 | 5.79% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $39,952,225 | 5.34% |
| MPM BioImpact LLC | 455,238 | $15,883,254 | 4.12% |
| ARK Investment Management | 9,420,782 | $328,691,084 | 2.85% |
| Atlas Venture Associates IX, LLC | 10,000 | $348,900 | 1.74% |
| Ghisallo Capital Management LLC | 250,000 | $8,722,500 | 1.55% |
| Nikko Asset Management Americas, Inc. | 2,976,002 | $103,743,430 | 1.49% |
| Prosight Management, LP | 72,116 | $2,516,127 | 1.37% |
| Rokos Capital Management LLP | 826,063 | $28,391,785 | 1.24% |
| Elmwood Wealth Management, Inc. | 67,899 | $2,368,996 | 1.18% |